Literature DB >> 13574826

The application of the fluorescent-antibody technique to haemagglutinating systems.

W R ALEXANDER.   

Abstract

Keywords:  ANTIBODIES

Mesh:

Substances:

Year:  1958        PMID: 13574826      PMCID: PMC1423928     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  2 in total

1.  Studies with marked antisera; quantitative studies with antisera marked with iodine 131isotope and their corresponding red-cell antigens.

Authors:  J C BOURSNELL; R R COOMBS; V RIZK
Journal:  Biochem J       Date:  1953-12       Impact factor: 3.857

2.  Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody.

Authors:  A H COONS; M H KAPLAN
Journal:  J Exp Med       Date:  1950-01-01       Impact factor: 14.307

  2 in total
  6 in total

1.  Incidence of the anti-nuclear factor in human sera.

Authors:  W R ALEXANDER; J M BREMNER; J J DUTHIE
Journal:  Ann Rheum Dis       Date:  1960-12       Impact factor: 19.103

2.  THODAMINE-CONJUGATED PAPAIN AS A COUNTERSTAIN IN FLUORESCENCE MICROSCOPY.

Authors:  W R ALEXANDER; J L POTTER
Journal:  Immunology       Date:  1963-09       Impact factor: 7.397

3.  [On the demonstration of erythrocytic antibodies with fluorescein-labelled antihuman globulin].

Authors:  K HAVEMANN
Journal:  Klin Wochenschr       Date:  1963-06-15

4.  Reaction of lupus erythematosus serum with nuclei of circulating and non-circulating cells.

Authors:  W R ALEXANDER; J J DUTHIE
Journal:  Br Med J       Date:  1958-12-27

5.  IMMUNOFLUORESCENT STAINING: THE FLUORESCENT ANTIBODY METHOD.

Authors:  E H Beutner
Journal:  Bacteriol Rev       Date:  1961-03

6.  IMMUNOREACTIONS INVOLVING PLATELETS. V. POST-TRANSFUSION PURPURA DUE TO A COMPLEMENT-FIXING ANTIBODY AGAINST A GENETICALLY CONTROLLED PLATELET ANTIGEN. A PROPOSED MECHANISM FOR THROMBOCYTOPENIA AND ITS RELEVANCE IN "AUTOIMMUNITY".

Authors:  N R Shulman; R H Aster; A Leitner; M C Hiller
Journal:  J Clin Invest       Date:  1961-09       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.